Berkeley Drosophila Genome Project
The Berkeley Drosophila Genome Project (BDGP) is a consortium of the Drosophila Genome Center, funded by the National Human Genome Research Institute, National Cancer Institute, and Howard Hughes...
www.fruitfly.org/ View full profile
| |
GALDERMA LABORATORIES L.P.
Since the creation of Galderma in 1981 as a joint venture between Nestlé and L'Oréal, all of our resources have been channelled in one direction: to provide innovative therapeutic solutions that meet...
www.galderma.com/ View full profile
| |
GammaCan
GammaCan is a biopharmaceutical company focused on clinical-phase development and commercialization. GammaCan’s initial therapy under development is a first-in-class anti-cancer immunotherapy aimed at...
www.gammacan.com/ View full profile
| |
GammaWest Brachytherapy
Brachytherapy is an advanced cancer treatment. The word "brachy" is Greek for "close by" and refers to placing radioactive seeds or sources directly in the tumor. This procedure gives physicians and...
www.gammawest.com/ View full profile
| |
GANYMED Pharmaceuticals AG
GANYMED Pharmaceuticals AG is developing monoclonal antibody therapeutics against solid tumors, where current therapies are poor and where there is an overriding medical need. The therapeutic efficacy...
www.ganymed-pharmaceuticals.com/ View full profile
| |
GeneSegues
GeneSegues is a biopharmaceutical company built upon advanced, targeted drug delivery technology. We conduct research and early-stage development of proprietary oncology biopharmaceuticals using our...
www.GENESEGUES.COM/ View full profile
| |
Genesis Genomics Inc.
Cancer is the leading cause of pre-mature death in Canada, being responsible for almost 1/3 of all potential years of life lost. During their life-time, 2 in 19 women are expected to develop breast...
www.genesisgenomics.com/ View full profile
| |
GloboZymes
GloboZymes is a leading provider of top quality signal transduction enzymes, proteins and antibodies.We maintain a cell signaling, cancer and apoptosis-related research program. Our purified protein...
www.globozymes.com/ View full profile
| |
Intracel
Intracel is a leading commercial-stage biotechnology company focused on the development of immune therapy to treat cancer. The company’s pipeline includes product development programs in active...
www.intracel.com/ View full profile
| |
Intradigm Corporation
Intradigm is developing siRNA-derived cancer therapeutics utilizing its proprietary RNAi technology. Intradigm has led the advancement of siRNA from the test tube to a potent, tissue-targeted,...
www.intradigm.com/ View full profile
| |
Geffen Visions International, Inc
Geffen Visions International, Inc. (GVI) is dedicated to creating leading-edge, multidimensional approaches to medicine, healing, wellness, and life. Our mission is to integrate advances in science,...
www.geffenvisions.com/ View full profile
| |
Gemin X Pharmaceuticals, Inc.
Gemin X Pharmaceuticals, Inc., specializes in the discovery and development of novel target-based cancer therapeutics. Gemin X's lead product, obatoclax (GX15-070), is a small molecule, pan-inhibitor...
www.geminx.com/ View full profile
| |
Gemvax AS
GemVax is a subsidiary of the Danish biotech company Pharmexa. The company is based on cancer vaccine technology developed over the last fourteen years at the Norwegian Radium Hospital in Oslo. GemVax...
www.gemvax.com/ View full profile
| |
Gendal Limited
Gendel Limited is developing a safe novel medical device technologu for the treatment of solod cancer tumours in the absence of any...
www.gendel.co.uk/ View full profile
| |
GeneMax
GeneMax develops innovative immunotherapies in the fields of oncology and infectious disease. Our patented technology restores or increases antigen processing and antigen specific immune responses....
www.GENEMAX.COM/ View full profile
| |
